Amorphous (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid
US8703956B2 · kind B2 · utility
5Cited by
11References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 7, 2012 |
| Grant date | Apr 22, 2014 |
| Priority date | — |
| Expiry date | Mar 14, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a stable amorphous form of (5-Fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid and its use in the treatment of conditions mediated by the action of PGD2 at the CRTH2 receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.